Document:

Supplemental Indenture, dated as of March 29, 2005

 Exhibit 4.1 
  

FLEXTRONICS INTERNATIONAL LTD. 
  
 up to € 300,000,000 
  
 9 3/4% SENIOR
SUBORDINATED NOTES DUE 2010 
  
 FIRST SUPPLEMENTAL INDENTURE

  
 Dated as of March 29, 2005 
  
 J.P. Morgan Trust Company, National Association 
 (as successor by merger to Chase Manhattan Bank and Trust Company, National Association) 
 as Trustee 

 FIRST SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of March
29, 2005, between Flextronics International Ltd., a Singapore corporation (the “Company”), and J.P. Morgan Trust Company, National Association (as successor by merger to Chase Manhattan Bank and Trust Company, National
Association (the “Original Trustee”)), as Trustee (the “Trustee”). 
  
 RECITALS 
  
 WHEREAS, the Company and the Original Trustee are parties to an Indenture, dated as of June 29, 2000 (the “Indenture”), pursuant to which the Company issued € 300,000,000 aggregate principal amount of 9 3/4% Senior Subordinated Notes due 2010 (the “Notes”); 
  
 WHEREAS, the Company desires to amend certain provisions of the Indenture as
set forth herein; 
  
 WHEREAS, pursuant to Section 9.02 of the
Indenture, the Company and the Trustee may amend certain terms of the Indenture with the written consent of the Holders of least a majority in aggregate principal amount of the outstanding Notes; 
  
 WHEREAS, the Company has offered to purchase for cash all of the Notes (the
“Offer”) and has solicited consents (the “Solicitation”) to certain amendments to the Indenture (the “Proposed Amendments”) pursuant to the Company’s Offer to Purchase for
Cash Any and All Outstanding 9 3/4% Senior Subordinated Notes due 2010 and Solicitation of Consents to Amendments
to the Related Indenture, dated March 1, 2005 (“Offer to Purchase”); 
  
 WHEREAS, the Company has obtained the written consent to the Proposed Amendments to the Indenture from the Holders of at least a majority in aggregate
principal amount of the outstanding Notes (the “Majority Consent”); and 
  
 WHEREAS, the execution and delivery of this Supplemental Indenture have been duly authorized by the parties hereto, and all conditions and requirements
necessary to make this instrument a valid and binding agreement have been duly performed and complied with; 
  
 NOW, THEREFORE, for and in consideration of the foregoing premises, it is mutually covenanted and agreed, for the equal and proportionate benefit of all
Holders of the Notes, as follows: 
  
 ARTICLE I 

 
 AMENDMENTS 
  
 SECTION 1.01. Effective upon the date the Company notifies the Trustee that
the Majority Consent and the Notes validly tendered and not validly withdrawn are accepted for payment pursuant to the Offer to Purchase: 
  
 (a) Removal of Certain Provisions, Defined Terms and Cross-References. The following Sections of the Indenture, and any corresponding provisions of
the Notes, are hereby deleted in their entirety and replaced with “Intentionally Omitted”: 
  

			
	 Existing Section / Article Number

	 	 Caption

	Section 4.08	 	Dividend and Other Payment Restrictions Affecting Restricted Subsidiaries
	Section 4.09	 	Incurrence of Debt and Issuance of Preferred Stock
	Section 4.11	 	Transactions with Affiliates
	Section 4.12	 	Liens
	Section 4.18	 	Status as Investment Company
	Section 4.19	 	Incurrence of Senior Subordinated Debt
	Clauses (vi) and (vii) of Section 8.04	 	Conditions to Legal or Covenant Defeasance

 Certain definitions in Sections 1.01 and 1.02 of the Indenture are also amended, modified or deleted as appropriate. Any
and all references in the Indenture to the deleted sections or provisions referred to above are deleted in their entirety. 
  
 (b) Amendment of Section 6.01(a)(iii). Section 6.01(a)(iii) of the Indenture is hereby amended by deleting the language in Section 6.01(a)(iii) in
its entirety and replacing it with the following: 
  
 “(iii) failure by the Company for 30 days after notice from either the Trustee or the Holders of at least 25% in principal amount of the then outstanding Notes to comply with the provisions described in Sections 4.07, 4.10, 4.14 or
5.01;” 
  
 ARTICLE II 
  
 GENERAL PROVISIONS 
  
 SECTION 2.01. Ratification of Indenture. Except as hereby
otherwise expressly provided, the Indenture is in all respects ratified and confirmed, and all the terms, provisions, and conditions thereof shall be and remain in full force and effect. 
  
 SECTION 2.02. Incorporation of Indenture. All the provisions of this Supplemental Indenture shall be deemed to be
incorporated in, and made a part of, the Indenture; and the Indenture, as supplemented and amended by this Supplemental Indenture, shall be read, taken and construed as one and the same instrument. 
  
 SECTION 2.03. Terms Defined. For all purposes of this Supplemental
Indenture, except as otherwise defined herein, capitalized terms used in this Supplemental Indenture shall have meanings ascribed to such terms in the Indenture. 
  
 SECTION 2.04. Counterparts. This Supplemental Indenture may be executed in any number of counterparts, each of which
shall be an original, but such counterparts shall together constitute but one and the same instrument. 
  
 SECTION 2.05. Governing Law. THIS SUPPLEMENTAL INDENTURE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.

  
 SECTION 2.06. References to This Supplemental
Indenture. Any and all notices, requests, certificates and other instruments executed and delivered after the execution and delivery of this Supplemental Indenture may refer to the Indenture without making specific reference to this Supplemental
Indenture, but nevertheless all such references shall include this Supplemental Indenture unless the context otherwise requires. 

 SECTION 2.07. Severability. In the event that any provisions of this Supplemental Indenture shall
be invalid, illegal, or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
  
 SECTION 2.08. Effect of Headings. The Section headings herein are for convenience only and shall not affect the
construction hereof. 
  
 SECTION 2.09. Trust Indenture Act.
If any provision hereof limits, qualifies or conflicts with another provision hereof which is required to be included in this Supplemental Indenture by any of the provisions of the Trust Indenture Act, the required provision shall control.

  
 SECTION 2.10. Effectiveness. Upon the execution and
delivery of this Supplemental Indenture by the parties hereto, the Supplemental Indenture will become effective but the Amendments will not become operative until at least a majority in aggregate principal amount of the outstanding Notes are validly
tendered and not validly withdrawn and accepted pursuant to and in accordance with the terms and conditions set forth in the Offer to Purchase of the Company, as the same may be amended, modified or supplemented from time to time in accordance
therewith. 
  
 SECTION 2.11 Trustee Makes No
Representation. The Trustee makes no representation as to the validity or sufficiency of this Supplemental Indenture. 
  
 [REMAINDER OF PAGE LEFT INTENTIONALLY BLANK] 

 IN WITNESS WHEREOF, each of the parties hereto have caused this Supplemental Indenture to be duly
executed as of the date first above written. 
  

			
	The Company:
	
	FLEXTRONICS INTERNATIONAL LTD.
		
	By:	 	 /s/ Manny Marimuthu

	Name:	 	Manny Marimuthu
	Title:	 	Authorized Signatory
	
	The Trustee:
	
	J.P. MORGAN TRUST COMPANY,
	NATIONAL ASSOCIATION, AS TRUSTEE
		
	By:	 	 /s/ Mary Jane Henson

	Name:	 	Mary Jane Henson
	Title:	 	Vice President

  
 [SIGNATURE PAGE TO THE FIRST SUPPLEMENTAL INDENTURE]2005 Stock Incentive Plan

 EXHIBIT 10.1 
  
 UNIVERSAL HEALTH SERVICES, INC. 
 2005 STOCK INCENTIVE PLAN 
  
 1. Purpose. The purpose of the Universal Health Services, Inc. 2005 Stock Incentive Plan (the “Plan”) is to provide a flexible vehicle through which Universal Health Services, Inc., a Delaware corporation (the
“Company”), may offer equity-based compensation incentives to key personnel of the Company and its affiliates in order to attract, motivate, reward and retain such personnel and to further align the interests of such personnel with those
of the stockholders of the Company. 
  
 2. Types of Awards.
Awards under the Plan may be in the form of (a) options to purchase shares of the Company’s Class B Common Stock, $.01 par value (the “Common Stock”) pursuant to Section 6 below, including options intended to qualify as
“incentive stock options” (“ISOs”) within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), and options which do not qualify as ISOs, and (b) stock appreciation rights
(“SARs”) pursuant to Section 7 below (collectively, “Awards”). 
  
 3. Share Limitations. 
  
 (a) Aggregate Share Limitation. Subject to adjustment as provided in Section 9 below, the maximum number of shares of Common Stock which may be issued pursuant to the Plan shall not exceed 4,000,000 shares (the “Authorized
Shares”). In determining the number of Authorized Shares available for issuance under the Plan, the following shares shall be deemed not to have been issued (and shall remain available for issuance) pursuant to the Plan: (i) shares subject to
an Award that is forfeited, canceled, terminated or settled in cash, and (ii) shares withheld or tendered by the recipient of an Award as payment of the exercise price under an Award or the tax withholding obligations associated with an Award.

  
 (b) Individual Award Limitation. Subject to adjustment
as provided in Section 9 below, the maximum number of shares of Common Stock with respect to which options or SARs may be granted hereunder during a calendar year of the Company to any employee is 1,000,000 shares. 
  
 4. Administration. 
  
 (a) Committee. The Plan shall be administered by the Compensation
Committee of the Company’s Board of Directors (the “Board”), or such other committee of directors designated by the Board (the “Committee”), provided that all of said designated directors qualify as “non-employee
directors” (within the meaning of Rule 16b-3(b)(3) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) and as “outside directors” (within the meaning of Treas. Reg. Section 1.162-27(e)(3) under
Section 162(m) of the Code). Notwithstanding the foregoing, the Board shall have sole responsibility and authority for matters relating to the grant and administration of Awards to non-employee directors of the Company, and reference herein to the
Committee with respect to any such matters shall be deemed to refer to the Board. 

 (b) Responsibility and Authority of Committee. Subject to the provisions of the Plan, the
Committee, acting in its discretion, shall have responsibility and full power and authority to (i) select the persons to whom Awards shall be made, (ii) prescribe the terms and conditions of each Award and make amendments thereto, (iii) construe,
interpret and apply the provisions of the Plan and of any agreement or other instrument evidencing an Award made under the Plan, and (iv) make any and all determinations and take any and all other actions as it deems necessary or desirable in order
to carry out the terms of the Plan. In exercising its responsibilities under the Plan, the Committee may obtain at the Company’s expense such advice, guidance and other assistance from outside compensation consultants and other professional
advisers as it deems appropriate. 
  
 (c) Delegation of
Authority. To the fullest extent authorized under Section 157(c) and other applicable provisions of the Delaware General Corporation Law, the Committee may delegate to any person or group or subcommittee of persons (who may, but need not be,
members of the Committee) such Plan-related functions within the scope of its responsibility, power and authority as it deems appropriate to the extent that such delegation shall not cause Awards intended to qualify as “performance-based
compensation” under Code Section 162(m) or intended to qualify for an exemption under Rule 16b-3 under the Exchange Act to fail to so qualify. 
  
 (d) Committee Actions. A majority of the members of the Committee shall constitute a quorum. The Committee may act by the vote of a majority of its
members present at a meeting at which there is a quorum or by unanimous written consent. The decision of the Committee as to any disputed question, including questions of construction, interpretation and administration, shall be final and conclusive
on all persons. The Committee shall keep a record of its proceedings and acts and shall keep or cause to be kept such books and records as may be necessary in connection with the proper administration of the Plan. 
  
 (e) Indemnification. The Company shall indemnify and hold harmless
each member of the Board, the Committee or any subcommittee appointed by the Committee and any employee of the Company who provides assistance with the administration of the Plan from and against any loss, cost, liability (including any sum paid in
settlement of a claim with the approval of the Board), damage and expense (including reasonable legal fees and other expenses incident thereto and, to the extent permitted by applicable law, advancement of such fees and expenses) arising out of or
incurred in connection with the Plan, unless and except to the extent attributable to such person’s fraud or willful misconduct. 
  
 5. Eligibility. Awards may be granted under the Plan to present or future employees of the Company or an affiliate of the Company and to directors
of, or consultants to, the Company or an affiliate who are not employees. For purposes hereof, “affiliate” of the Company means a person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is
under common control with, the Company. 
  
 6. Stock
Options. Stock options granted under the Plan shall have such vesting and other terms and conditions as the Committee, acting in its discretion in accordance with the Plan, may determine, either at the time the option is granted or, if the
holder’s rights are not adversely affected, at any subsequent time. The Committee may impose restrictions on shares of Common Stock acquired upon the exercise of options granted under the Plan. 
  

 - 2 - 

 (a) Exercise Price. The exercise price per share of Common Stock covered by an option granted
under the Plan may not be less than 100% of the Fair Market Value (as defined in Section 8 below) of a share of Common Stock on the date the option is granted (110% in the case of ISOs granted to an employee who is a 10% stockholder within the
meaning of Section 422(b)(6) of the Code). 
  
 (b) Option
Term. Unless sooner terminated in accordance with its terms, an option shall automatically expire on the tenth anniversary of the date it is granted (the fifth anniversary of the date it is granted in the case of an ISO granted to an employee
who is a 10% stockholder). 
  
 (c) Manner of Exercise. An
outstanding and exercisable option may be exercised by transmitting to the Secretary of the Company (or other person designated for this purpose by the Committee) a written notice identifying the option that is being exercised and specifying the
number of shares to be purchased pursuant to that option, together with payment of the exercise price, and by satisfying the applicable tax withholding obligations pursuant to Section 10. The Committee may establish such rules and procedures as it
deems appropriate for the exercise of options under the Plan. The Committee, acting in its sole discretion, may permit the exercise price to be paid in whole or in part in cash or by check, by means of a cashless exercise procedure, in the form of
unrestricted shares of Common Stock (to the extent of the Fair Market Value thereof) or, subject to applicable law, by any other form of consideration deemed appropriate. 
  
 (d) Rights as a Stockholder. No shares of Common Stock shall be issued in respect of the exercise of an option until
payment of the exercise price and the applicable tax withholding obligations have been satisfied or provided for to the satisfaction of the Company. The holder of an option shall have no rights as a stockholder with respect to any shares covered by
the option until the option is validly exercised, the exercise price is paid fully and applicable withholding obligations are satisfied fully. 
  
 (e) Nontransferability of Options. No option granted under the Plan may be assigned or transferred except upon the option holder’s death to a
beneficiary designated by the option holder in a manner prescribed or approved for this purpose by the Committee or, if no designated beneficiary shall survive the option holder, pursuant to the option holder’s will or by the laws of descent
and distribution; and each such option may be exercised during the option holder’s lifetime only by the option holder. Notwithstanding the preceding sentence, the Committee may, in its sole discretion, permit an option holder to transfer an
option, other than an ISO, in whole or in part, to such persons and/or entities as are approved by the Committee from time to time and subject to such terms and conditions as the Committee may determine from time to time. 
  
 (f) Termination of Employment or Other Service. Unless otherwise
determined by the Committee in its sole discretion, if an option holder ceases to be employed by or to perform other services for the Company and its affiliates for any reason other than death or 
  

 - 3 - 

 disability (defined below), then each outstanding option granted to him or her under the Plan will terminate on the date
of termination of employment or other service or, if earlier, the date specified in the option agreement. Unless otherwise determined by the Committee in its sole discretion, if an option holder’s employment or service is terminated by reason
of the option holder’s death or disability (or if the option holder’s employment or other service is terminated by reason of his or her disability and the option holder dies within one year after such termination of employment or service),
then each outstanding option granted to the option holder under the Plan will terminate on the date one year after the date of such termination of employment or other service (or one year after the later death of a disabled option holder) or, if
earlier, the date specified in the option agreement. For purposes hereof, unless otherwise determined by the Committee, the term “disability” means the inability of an Award holder to perform the customary duties of his or her employment
or other service for the Company or its affiliates by reason of a physical or mental incapacity which is expected to result in death or be of indefinite duration. 
  
 7. Stock Appreciation Rights. A SAR constitutes a conditional right of the holder to receive, in shares of Common
Stock of equivalent value, an amount equal to the Fair Market Value of a share of Common Stock on the applicable exercise or designated settlement date minus a specified base price. SARs granted under the Plan shall have such vesting and other terms
and conditions as the Committee, acting in its discretion in accordance with the Plan, may determine, either at the time the SAR is granted or, if the holder’s rights are not adversely affected, at any subsequent time. The Committee may impose
restrictions on shares acquired upon the exercise of SARs granted under the Plan. 
  
 (a) Base Price. The base price per share of Common Stock covered by an SAR granted under the Plan may not be less than the Fair Market Value of a share of Common Stock on the date the SAR is granted.

  
 (b) SAR Term. Unless sooner terminated in accordance
with its terms, a SAR shall automatically expire on the tenth anniversary of the date it is granted. 
  
 (c) Exercise of SARs. An outstanding and exercisable SAR may be exercised by transmitting to the Secretary of the Company (or other person
designated for this purpose by the Committee) a written notice identifying the SAR that is being exercised, specifying the number of shares covered by the exercise and containing such other information or statements as the Committee may require, and
by satisfying the applicable tax withholding obligations pursuant to Section 10. The Committee may establish such rules and procedures as it deems appropriate for the exercise of SARs under the Plan. Upon the exercise of an SAR (or designated
settlement date, if applicable), the holder shall be entitled to receive an amount in shares of Common Stock equal to the product of (i) the number of shares of Common Stock with respect to which the SAR is being exercised (or settled) and (ii) the
difference between the Fair Market Value of a share of Common Stock on the date the SAR is exercised (or settled) and the base price per share of the SAR. 
  
 (d) Nontransferability of SARs. No SARs granted under the Plan may be assigned or transferred except upon the SAR holder’s death to a
beneficiary designated by the SAR holder in a manner prescribed or approved for this purpose by the Committee or, if no 
  

 - 4 - 

 designated beneficiary shall survive the SAR holder, pursuant to the SAR holder’s will or by the laws of descent and
distribution; and each such SAR may be exercised during the SAR holder’s lifetime only by the SAR holder. 
  
 (e) Termination of Employment or Other Service. Unless otherwise determined by the Committee in its sole discretion, if a SAR holder ceases to be
employed by or to perform other services for the Company and its affiliates for any reason other than death or disability (defined above), then each outstanding SAR granted to him or her under the Plan will terminate on the date of termination of
employment or other service or, if earlier, the date specified in the SAR agreement. Unless otherwise determined by the Committee in its sole discretion, if a SAR holder’s employment or service is terminated by reason of the SAR holder’s
death or disability (or if the SAR holder’s employment or other service is terminated by reason of his or her disability and the SAR holder dies within one year after such termination of employment or service), then each outstanding SAR granted
to the SAR holder under the Plan will terminate on the date one year after the date of such termination of employment or other service (or one year after the later death of a disabled SAR holder) or, if earlier, the date specified in the SAR
agreement. 
  
 8. Fair Market Value. For Plan purposes,
unless otherwise required by applicable law, the “Fair Market Value” means the fair market value of a share of Common Stock as determined in good faith by the Committee or under procedures established by the Committee. Unless otherwise
determined by the Committee, the Fair Market Value of a share of Common Stock as of any given date shall be the closing sale price per share of the Common Stock reported on a consolidated basis for securities listed on the principal stock exchange
or market on which the Common Stock is traded on the date as of which such value is being determined or, if there is no sale on that day, then on the next day on which a sale was reported. 
  
 9. Capital Changes; Merger, Consolidation, Asset Sale. 
  
 (a) Adjustments upon Changes in Capitalization. The maximum number
and class of shares issuable pursuant to the Plan, the maximum number of shares with respect to which options or SARs may be granted to any employee in any calendar year, the number and class of shares and the exercise price per share covered by
each outstanding option and the number and class of shares and the base price per share covered by each outstanding SAR shall all be adjusted proportionately or as otherwise appropriate to reflect any increase or decrease in the number of issued
shares of Common Stock resulting from a split-up or consolidation of shares or any like capital adjustment, or the payment of any stock dividend, and/or to reflect a change in the character or class of shares covered by the Plan arising from a
readjustment or recapitalization of the Company’s capital stock. 
  
 (b) Effects of Merger, Consolidation or Asset Sale. In the event of a merger or consolidation of the Company with or into another corporation, or the sale of all or substantially all of the assets of the Company, each outstanding
option and SAR shall be assumed or an equivalent option or right substituted by the successor corporation (or a parent of the successor corporation). In the event that the successor corporation refuses to assume or substitute for options or SARs,
the option holders and SAR holders shall fully vest in and have the right to exercise their options and SARs as to all of the shares covered thereby, including 
  

 - 5 - 

 shares as to which it would not otherwise be vested or exercisable. If an option or SAR becomes fully vested and
exercisable in lieu of assumption or substitution in the event of a merger, consolidation or sale of assets, the Board shall notify the holder in writing or electronically at least fifteen (15) days prior to the consummation of such merger,
consolidation or sale of assets that the option and/or SAR shall be fully exercisable for the period specified in such notice (but in any case not less than fifteen (15) days from the date of such notice), and the option and/or SAR shall terminate
upon the consummation of such merger, consolidation or asset sale. For the purposes of this Section, an option or SAR shall be considered assumed if, following the merger, consolidation or sale of assets, the option or SAR confers the right to
purchase or receive, for each share of stock subject to the option or SAR immediately prior to the merger, consolidation or sale of assets, the consideration (whether stock, cash or other securities or property) received in the merger, consolidation
or sale of assets by holders of Common Stock for each share held on the effective date of the transaction (reduced, in the case of SARs, by the applicable base price) and if holders were offered a choice of consideration, the type of consideration
chosen by the holders of a majority of the outstanding shares); provided, however, that if such consideration received in the merger, consolidation or sale of assets is not solely common stock of the successor corporation or its parent, the Board
may, with the consent of the successor corporation, provide for the consideration to be received upon the exercise of the option or SAR, for each share of stock subject to the option or SAR, to be solely common stock of the successor corporation or
its parent equal in fair market value to the per share consideration received by holders of Common Stock in the merger, consolidation or sale of assets (reduced, in the case of SARs, by the applicable base price). 
  
 (c) Change in Control. The Board may in its sole discretion
accelerate, in whole or in part, the vesting of any outstanding Award upon the occurrence of a Change in Control (as defined below), whether or not the vesting requirements set forth in the applicable Award agreement have been satisfied. For
purposes hereof, a “Change in Control” of the Company shall be deemed to occur if: (i) there occurs (1) any consolidation or merger in which the Company is not the continuing or surviving entity or pursuant to which each class of the
Company’s common stock would be converted into cash, securities or other property, other than (x) a consolidation or merger of the Company in which the holders of each class of common stock immediately prior to the consolidation or merger have
the same proportionate ownership and voting power with respect to the common stock of the surviving corporation immediately after the consolidation or merger, or (y) a consolidation or merger which would result in the voting securities of the
Company outstanding immediately prior thereto continuing to represent (by being converted into voting securities of the continuing or surviving entity) more than 50% of the combined voting power of the voting securities of the surviving or
continuing entity immediately after such consolidation or merger and which would result in the members of the Board immediately prior to such consolidation or merger (including, for this purpose, any individuals whose election or nomination for
election was approved by a vote of at least two-thirds of such members), constituting a majority of the board of directors (or equivalent governing body) of the surviving or continuing entity immediately after such consolidation or merger; or (2)
any sale, lease, exchange or other transfer (in one transaction or a series of related transactions) of all or substantially all the Company’s assets; 
  

 - 6 - 

 (ii) the Company’s stockholders approve any plan or proposal for the liquidation or dissolution of
the Company; 
  
 (iii) any person (as such term is used in
Sections 13(d) and 14(d)(2) of the Exchange Act), other than persons or their family members or affiliates which have such voting power on the date of adoption of the Plan by the Board, shall become the beneficial owner (within the meaning of Rule
13d-3 under the Exchange Act) of 35% or more of the combined voting power of the voting securities of the Company other than pursuant to a plan or arrangement entered into by such person and the Company; or 
  
 (iv) during any period of two consecutive years, individuals who at the
beginning of such period constitute the entire Board shall cease for any reason to constitute a majority of the Board unless the election or nomination for election by the Company’s stockholders of each new director was approved by a vote of at
least two-thirds of the directors then still in office who were directors at the beginning of the period. 
  
 (d) Fractional Shares. In the event of any adjustment in the number of shares covered by any Award pursuant to the provisions hereof, any
fractional shares resulting from such adjustment shall be disregarded and each such Award shall cover only the number of full shares resulting from the adjustment. 
  
 (e) Determination of Board to be Final. All adjustments under this Section shall be made by the Board, and its
determination as to what adjustments shall be made, and the extent thereof, shall be final, binding and conclusive. 
  
 10. Tax Withholding. As a condition to the exercise of any Award, the delivery of any shares of Common Stock pursuant to any Award or the
settlement of any Award, or in connection with any other event that gives rise to a federal or other governmental tax withholding obligation on the part of the Company or an affiliate relating to an Award, the Company and/or the affiliate may (a)
deduct or withhold (or cause to be deducted or withheld) from any payment or distribution to an Award recipient whether or not pursuant to the Plan or (b) require the recipient to remit cash (through payroll deduction or otherwise), in each case in
an amount sufficient in the opinion of the Company to satisfy such withholding obligation. If the event giving rise to the withholding obligation involves a transfer of shares of Common Stock, then, at the sole discretion of the Committee, the
recipient may satisfy the withholding obligation described under this Section by electing to have the Company withhold shares of Common Stock or by tendering previously-owned shares of Common Stock, in each case having a Fair Market Value equal to
the amount of tax to be withheld (or by any other mechanism as may be required or appropriate to conform with local tax and other rules). 
  
 11. Amendment and Termination. The Board may amend or terminate the Plan provided, however, that no such action may adversely affect a
holder’s rights under an outstanding Award without his written consent. Any amendment which would (a) increase the maximum number of shares of Common Stock issuable under the Plan or the maximum number of shares with respect to which options or
SARs may be granted to any employee in any calendar year, (b) modify the class of persons eligible to receive Awards under the Plan or (c) otherwise require stockholder approval under applicable law or exchange or market requirements, shall, to the
extent required by applicable law or exchange or market requirements, be subject to the approval of the Company’s stockholders. 
  

 - 7 - 

 12. Limitation on Repricing. Without the approval of the Company’s stockholders, the
Committee shall not amend or replace previously granted options in a transaction that constitutes a “repricing,” as such term is used in Section 303A.08 of the Listed Company Manual of the New York Stock Exchange, Inc. 
  
 13. General Provisions. 
  
 (a) Documentation of Awards. Each Award made under the Plan shall be
evidenced by a written agreement or other instrument the terms of which shall be established by the Committee. To the extent not inconsistent with the provisions of the Plan, the written agreement or other instrument evidencing an Award shall govern
the rights and obligations of the Award recipient (and any person claiming through the recipient) with respect to the Award. 
  
 (b) Shares Issued under Plan. Shares of Common Stock available for issuance under the Plan may be authorized and unissued, held by the Company in
its treasury or otherwise acquired for purposes of the Plan. No fractional shares of Common Stock shall be issued under the Plan. 
  
 (c) Compliance with Law. The Company shall not be obligated to issue or deliver shares of Common Stock pursuant to the Plan unless the issuance and
delivery of such shares complies with applicable law, including, without limitation, the Securities Act of 1933, as amended, the Exchange Act and the requirements of any stock exchange or market upon which the Common Stock may then be listed, and
shall be further subject to the approval of counsel for the Company with respect to such compliance. 
  
 (d) Transfer Orders; Placement of Legends. All certificates for shares of Common Stock delivered under the Plan shall be subject to such stock
transfer orders and other restrictions as the Company may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange or market upon which the Common Stock may then be listed, and
any applicable federal or state securities law. The Company may cause a legend or legends to be placed on any such certificates to make appropriate reference to such restrictions. 
  
 (e) No Employment or other Rights. Nothing contained in the Plan or in any Award agreement shall confer upon any
recipient of an Award any right with respect to the continuation of his or her employment or other service with the Company or an affiliate or interfere in any way with the right of the Company and its affiliates at any time to terminate such
employment or other service or to increase or decrease, or otherwise adjust, the other terms and conditions of the recipient’s employment or other service. 
  

(f) Decisions and Determinations Final. Except to the extent rights or powers under the Plan are reserved specifically to the discretion of the
Board, the Committee shall have full power and authority to interpret the Plan and any Award agreement made under the Plan and to determine all issues which arise thereunder or in connection therewith, and the decision of the Board or the Committee,
as the case may be, shall be binding and conclusive on all interested persons. 
  

 - 8 - 

 (g) Nonexclusivity of the Plan. No provision of the Plan, and neither its adoption Plan by
the Board or submission to the stockholders for approval, shall be construed as creating any limitations on the power of the Board or a committee thereof to adopt such other incentive arrangements, apart from the Plan, as it may deem desirable,
including incentive arrangements and awards which do not qualify as “performance-based compensation” under Section 162(m) of the Code. 
  
 14. Governing Law. All rights and obligations under the Plan and each Award agreement or instrument shall be governed by and construed in
accordance with the laws of the State of Delaware, without regard to its principles of conflict of laws. 
  
 15. Term of the Plan. The Plan shall become effective on the date it is approved by the Company’s stockholders (the “Effective
Date”). Unless sooner terminated by the Board, the Plan shall terminate on the tenth anniversary of the Effective Date. The rights of any person with respect to an Award made under the Plan that is outstanding at the time of the termination of
the Plan shall not be affected solely by reason of the termination of the Plan and shall continue in accordance with the terms of the Award and of the Plan, as each is then in effect or is thereafter amended. 
  

 - 9 -

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}]]